May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Apothecary Labs operated as a single-category brand with Topical accounting for 100.0% of sales, pairing a year-over-year sales change of -3.16% with a month-over-month decline of -38.45%. Average price increased 24.20% year over year to $33.31, while overall brand sales fell -3.16% YoY, indicating that volume contracted even as pricing rose. The combination of a 310.32% 24-month sales increase and a steep May 2026 MoM pullback suggests demand volatility within a concentrated portfolio. The pattern implies that reliance on one category magnifies short-term swings and that May 2026 performance was driven more by unit softness than by price moves.
With Topical at 100.0% share in British Columbia, the -38.45% MoM swing compresses near-term shelf momentum even as the 24.20% YoY price lift signals a higher-value positioning. The -3.16% YoY sales dip alongside a 310.32% 24-month increase indicates that Apothecary Labs has expanded materially over two years but is now hitting sensitivity to price or seasonal cycles within Topical. The pattern implies that, without category diversification or targeted price-pack architecture, short-term rank stability in Topical will remain vulnerable to monthly demand shocks.
Competitive Landscape
Apothecary Labs is ranked #6 in BC Topical in May 2026, improving 2 positions from #8 year over year, and matching its 3-month position at #6 while setting a peak rank of #6 in May 2026; by contrast, Proofly held #1 both year over year and currently, and Wildflower climbed from #7 to #3 with a 525.6% YoY sales change as Wildflower Canada fell from #2 to #5 with a -24.3% YoY sales change. The combination of a 2-rank YoY gain and a ceiling at #6 implies Apothecary Labs is consolidating a mid-tier position rather than breaking into the top five without a change in velocity drivers.

Notable Products
CBD Maximum Strength Roll-On Gel (2000mg CBD, 88g) fell 37.9% month over month in May 2026 while still holding rank 1, a mix of contraction and category control that points to over-reliance on a single flagship. With no ranked presence for CBD Maximum Strength Mini Roll-On Gel (1000mg CBD) and CBD:THC 2:1 Extra Strength Roll On (180mg CBD, 60mg THC, 88g), two unranked SKUs suggest concentration risk as 100% of the top spot volume sits in one Topical. The flagship’s decline alongside maintained rank implies market-wide softness or price-led share defense rather than unit expansion, steering Apothecary Labs toward shoring up distribution and price-pack architecture before scaling secondary SKUs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







